Serial Angiography in Patients with Acute Coronary Syndromes: Effect of Antithrombotic Therapy on Angiographic Lesion Severity

Heart Lung and Circulation

Volumn 15, Issue 6, 2006, Pages 378-382

  Prasan, Ananth M ^a   Bhagwandeen, Rohan ^a   Solanki, Victor J ^a   Freedman, S Benjamin ^a   Brieger, David ^a  

^a ANZAC Research Institute   (Australia)

Author keywords

Acute coronary syndromes; Angioplasty; Plaque remodelling

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DRUG THERAPY, COMBINATION; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 33751425658     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2006.09.001     Document Type: Article

References (19)

1. De Winter R.J., Windhausen F., Cornel J.H., Dunselman P.H., Janus C.L., Bendermacher P.E., et al. Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med 353 11 (2005) 1095-1104
2. Wallentin L., Lagerqvist B., Husted S., Kontny F., Stahle E., and Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. Lancet 356 (2000) 9-16
3. FRISC II Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet 354 (1999) 708-715
4. Fox K.A., Poole-Wilson P.A., Henderson R.A., Clayton T.C., Chamberlain D.A., Shaw T.R., et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet 360 9335 (2002) 743-751
5. Cannon C.P., Weintraub W.S., Demopoulos L.A., Vicari R., Frey M.J., Lakkis N., et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. Thrombolysis in Myocardial Infarction Investigators 18. N Engl J Med 344 (2001) 1879-1887
6. Mahoney E.M., Jurkovitz C.T., Chu H., Becker E.R., Culler S., Kosinski A.S., et al. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction. Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction. J Am Med Assoc 288 15 (2002) 1851-1858
7. OASIS Registry Investigators. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. Lancet 352 (1998) 507-514
8. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 138 (1999) S419-S420
9. SPSS Version 11.5.1 SPSS Inc. Chicago, Ill; 2002.
10. Holmes Jr. D.R. Acute coronary syndromes: extending medical intervention for five days before proceeding to revascularization. Am J Cardiol 86 12B (2000) 36M-41M
11. Topol E.J., Fuster V., Harrington R.A., Califf R.M., Kleimann N.S., Kereiakes D.J., et al. Recombinant hirudin for unstable angina pectoris. A multicenter randomized angiographic trial. Circulation 89 4 (1994) 1557-1566
12. Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial. Circulation 1993;87(1):38-52.
13. Van de Werf F., Gore J.M., Avezum A., Gulba D.C., Goodman S.G., Budaj A., et al. Access to catheterization facilities in patients admitted with acute coronary syndrome: multinational registry study. Br Med J 330 7489 (2005) 441
14. Zhao X.-Q., Theroux P., Snapinn S.M., and Sax F.L. Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non Q wave myocardial infarction. Circulation 100 (1999) 1609-1615
15. Hamm C.W., Heeschen C., Goldmann B., Vahanina A., Adgey J., Miguel C.M., et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels: C7E3 fab AntiPlatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. Lancet 349 (1997) 1429-1435
16. Smith Jr. S.C., Feldman T.E., Hirshfeld Jr. J.W., Jacobs A.K., Kern M.J., King III S.B., Morrison D.A., O'Neil W.W., Schaff H.V., Whitlow P.L., Williams D.O., Antman E.M., Adams C.D., Anderson J.L., Faxon D.P., Fuster V., Halperin J.L., Hiratzka L.F., Hunt S.A., Nishimura R., Ornato J.P., Page R.L., and Riegel B. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography and Interventions Writing Committee to Update 2001 Guidelines for Percutaneous Intervention. Circulation 113 1 (2006) 156-175
17. Shah P.K. Mechanism of plaque vulnerability and rupture. J Am Coll Cardiol 41 4 Suppl. S (2003) 15S-22S
18. Varnava A.M., Mills P.G., and Davies M.J. Relationship between coronary artery remodelling and plaque vulnerability. Circulation 105 8 (2002) 939-943
19. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2001) 494-502